Radioiodine treatment complications to the mother and child in patients with differentiated thyroid carcinoma

Hellenic Journal of Nuclear Medicine

Volumn 12, Issue 1, 2009, Pages 37-40

  Fard Esfahani, Armaghan ^a   Hadifar, Mahsa ^a   Fallahi, Babak ^a   Beiki, Davood ^a,b   Eftekhari, Mohammad ^a   Saghari, Mohsen ^a   Takavar, Abbas ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

131; Abortion; Congenital abnormalities; Differentiated thyroid carcinoma; I; Radioiodine treatment

Indexed keywords

IODINE 131;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONGENITAL MALFORMATION; CONTROLLED STUDY; DOWN SYNDROME; DRUG MEGADOSE; FEMALE; FETUS DEATH; GENETIC RISK; HEALTH STATUS; HEART DISEASE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD; MICROCEPHALY; PREGNANCY OUTCOME; PREGNANT WOMAN; RETROSPECTIVE STUDY; SIDE EFFECT; SPONTANEOUS ABORTION; THYROID CARCINOMA; UNDIFFERENTIATED CARCINOMA;

ADOLESCENT; ADULT; COMORBIDITY; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; IODINE RADIOISOTOPES; IRAN; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PRENATAL EXPOSURE DELAYED EFFECTS; RADIATION INJURIES; RADIOPHARMACEUTICALS; RADIOTHERAPY; RISK ASSESSMENT; RISK FACTORS; THYROID NEOPLASMS; YOUNG ADULT;

EID: 64949124002     PISSN: 11081430     EISSN: 17905427     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lind P, Differentiated thyroid carcinoma, Ell P, Gambhir S, Nuclear medicine in clinical diagnosis and treatment, 3rd edn, vol 2, Churchill & Livingstone publ London. An Imprint of Elsevier, 2004: 145-164.
2. Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab 2001; 86: 1447-1463.
3. Tuttle RM, Becker DV, Harley JR. Radioiodine treatment of thyroid diseases. In: Sandler MP, Coleman RE, Patton JA et al. Diagnostic Nuclear Medicine, 4th edn, New York, Lippincott Williams & Wilkins 2003: 653-671.
4. 131I therapy for thyroid cancer. Clin Endocrionol 2002; 57: 313-314.
5. Bal C, Kumar A, Tripathi M et al. High-dose radioiodine treatment for differentiated thyroid carcinoma is not associated with change in female fertility or any genetic risk to the offspring. Int J Radiat Oncol Biol Phys 2005; 63: 449-455.
6. Schlumberger M, De Vathaire F, Ceccarelli C et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996; 37: 606-612.
7. Otake M, Schull WJ, Neel JV. Congenital malformations, stillbirths and early mortality among the children of atomic bomb survivors: a re-analysis. Radiat Res 1990; 122: 1-11.
8. Chow SM, Yau S, Lee SH et al. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment. Int J Radiat Oncol Biol Phys 2004; 59: 992-1000.
9. Dottorini ME, Lomuscio G, Mazzucchelli L et al. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995; 36: 21-27.
10. Balenović A, Vlasić M, Sonicki Z et al. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma. Coll Antropol 2006; 30: 743-748.
11. Trokoudes KM, Skordis N, Picolos MK, Infertility and thyroid disorders, Curr Opin Obstet Gynecol 2006; 18: 446-451.
12. Sioka C, Kouraklis G, Zafirakis A et al. Menstrual cycle disorders after therapy with iodine-131. Fertil Steril 2006; 86: 625-628.
13. Vini L, Hyer S, Al-Saadi A et al. Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 2002; 78(916): 92-93.
14. Souza RPW, Alvarenga FT, Boas FAS et al. Ovarian function after radioiodine therapy in patients with thyroid cancer. Exp Clin Endocrinol Diabetes 2005; 113: 331-333.
15. Raymond JP, Izembart M, Marliac V et al. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab 1989; 69: 186-190.
16. 131I therapy for differentiated thyroid cancer leads to an earlier onset of menopause: results of a retrospective study. J Clin Endocrinol Metab 2001; 86: 3512-3515.
17. Lin JD, Wang HS, Weng HF, Kao PF. Outcome of pregnancy after radioactive iodine treatment for well differentiated thyroid carcinomas. J Endocrinol Invest 1998; 21: 662-667.
18. Krassas GE, Thyroid disease and female reproduction. Fertil Steril 2000; 74: 1063-1070.
19. 131I. Hell J Nucl Med 2004; 7: 52-55.
20. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC. Williams Obstetrics, 22nd edn. McGraw-Hill, New York, 2005.
21. Nojomi M, Akbarian A, Ahory-Moghadam S et al. Burden of abortion: induced and spontaneous. Arch Iranina Med. 2006; 9: 39-45.
22. Horne AW, Alexander CI. Recurrent miscarriage. J Fam Plann Reprod Health Care 2005; 31(2): 103-107.
23. Rachel A. Powsner RA. Essentials of nuclear medicine physics, Blackwell publishing, USA, 1998; 164-178.
24. Ehrenheim C, Hauswirth C, Fitschen J et al. Genetic risk after high dose radioiodine therapy with regard to gonadal dose. Nuklearmedizin 1997; 36: 157-166.
25. Izembart M, Chavaudra J, Aubert B, Vallée G. Retrospective evaluation of the dose received by the ovary after radioactive iodine therapy for thyroid cancer. Eur J Nucl Med 1992; 19: 243-247.
26. Ayala C, Navarro E, Rodriguez JR et al. Conception after iodine-131 therapy for differentiated thyroid cancer. Thyroid 1998; 8: 1009-1011.
27. do Rosário PW, Barroso AL, Rezende LL et al. Malformations in the offspring of women with thyroid cancer treated with radioiodine for the ablation of thyroid remnants. Arq Bras Endocrinol Metabol 2006; 50: 930-933.
28. Balenović A, Vlasić M, Sonicki Z et al. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma. Coll Antropol 2006; 30(4): 743-748.